Clinical Trial Update: A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ZKAB001 (PD-L1 antibody) in limited stage high-grade osteosarcoma, across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• ZKAB001 (PD-L1 antibody)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Osteosarcoma | Phase 1, Phase 2 | Status: UNKNOWN